Alcon Results Pose Questions About 2027 Outlook

Dow Jones
11/11

1056 GMT - Alcon's third-quarter results were worse than expected and raise questions about the eyecare specialist's outlook for next year, Jefferies analysts say in a note. Investors had lower expectations for the third-quarter results, but the update was still worse than anticipated, the analysts say. Revenue missed consensus estimates and full-year guidance was mostly lowered at the midpoint of the new narrowed ranges, even if third-quarter earnings beat forecasts, they add. Competitive pressure that has weighed on sales of Alcon's implantable products could persist into the fourth quarter, Jefferies says. Zurich-listed shares fall 5.6%.

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10